---
figid: PMC12255454__gr6
figtitle: The sphingolipid metabolic pathway and biochemical tools for its investigation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12255454
filename: gr6.jpg
figlink: /pmc/articles/PMC12255454/figure/F6/
number: F6
caption: 'Schematic of the sphingolipid metabolic pathway and biochemical tools for
  its investigation. Synthesis of canonical sphingolipids (indicated in black) starts
  with the condensation of L-serine and palmitoyl-CoA by SPT. L-alanine (L-Ala) or
  glycine (Gly) can also be utilized instead of serine to produce deoxysphingolipids
  (deoxysphingolipids are reported in light pink). In red are inhibitors available
  to researchers. Whereas many additional inhibitors have also been reported in the
  literature, in this Figure we are indicating the more specific ones. In green are
  the various precursors that can be utilized to study flux through the pathway or
  through a specific metabolic node. ∗: indicates that the molecule is labeled (lipid
  precursors can be traced isotopically, radioactively or complexed to a fluorescent
  moiety; toxins may be fused to small fluorescent reporter proteins such as green
  or red fluorescent proteins). #Sph: these are bi- or tri-functionalized sphingolipid
  analogs. ˆFADS3: This enzyme introduces a Δ14,15 cis double bond onto deoxy(methyl)DHCer
  or deoxy(methyl)dhsphingosine to form deoxy(methyl)ceramide or deoxy(methyl)sphingosine,
  respectively. For canonical sphingolipids, DES introduces a Δ4,5 cis double bond
  onto dhCeramide to form ceramide. Abs: antibodies'
papertitle: The bioactive sphingolipid playbook. A primer for the uninitiated as well
  as sphingolipidologists
reftext: Yusuf A. Hannun, et al. J Lipid Res. 2025 Jun;66(6).
year: '2025'
doi: 10.1016/j.jlr.2025.100813
journal_title: Journal of Lipid Research
journal_nlm_ta: J Lipid Res
publisher_name: American Society for Biochemistry and Molecular Biology
keywords: pathway analysis | targeted lipidomics | untargeted lipidomics
automl_pathway: 0.914204
figid_alias: PMC12255454__F6
figtype: Figure
redirect_from: /figures/PMC12255454__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12255454__gr6.html
  '@type': Dataset
  description: 'Schematic of the sphingolipid metabolic pathway and biochemical tools
    for its investigation. Synthesis of canonical sphingolipids (indicated in black)
    starts with the condensation of L-serine and palmitoyl-CoA by SPT. L-alanine (L-Ala)
    or glycine (Gly) can also be utilized instead of serine to produce deoxysphingolipids
    (deoxysphingolipids are reported in light pink). In red are inhibitors available
    to researchers. Whereas many additional inhibitors have also been reported in
    the literature, in this Figure we are indicating the more specific ones. In green
    are the various precursors that can be utilized to study flux through the pathway
    or through a specific metabolic node. ∗: indicates that the molecule is labeled
    (lipid precursors can be traced isotopically, radioactively or complexed to a
    fluorescent moiety; toxins may be fused to small fluorescent reporter proteins
    such as green or red fluorescent proteins). #Sph: these are bi- or tri-functionalized
    sphingolipid analogs. ˆFADS3: This enzyme introduces a Δ14,15 cis double bond
    onto deoxy(methyl)DHCer or deoxy(methyl)dhsphingosine to form deoxy(methyl)ceramide
    or deoxy(methyl)sphingosine, respectively. For canonical sphingolipids, DES introduces
    a Δ4,5 cis double bond onto dhCeramide to form ceramide. Abs: antibodies'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SPTSSA
  - SPTLC1
  - AGXT
  - SPTSSB
  - SPTLC2
  - ORMDL2
  - ORMDL3
  - ORMDL1
  - KDSR
  - SEMA6A
  - CYP4F3
  - CYP2B6
  - CERS3
  - CERS5
  - CERS6
  - CERS2
  - CERS4
  - CERS1
  - GDF1
  - TFPT
  - GCLC
  - UGCG
  - DEGS1
  - SGMS2
  - DDX41
  - FADS3
  - DOK7
  - DEGS2
  - GBA1
  - GBA1LP
  - CERT1
  - SGMS1
  - SAMD8
  - ASAH1
  - ACER2
  - ACER3
  - ACER1
  - SFTA3
  - ASAH2
  - SMPD1
  - SMPD3
  - DGAT1
  - DGAT2
  - KCNN1
  - PAPSS1
  - KCNN2
  - PAPSS2
  - SPHK2
  - MBTPS1
  - Galactosylceramide
  - cytochrome
  - Gangliosides
  - FB1
  - NBD-C6-Cer
  - Eliglustat
  - Glucosylceramide
  - Sphingomyelin
  - Ceramide
  - Carmofur
  - Sphingosine
---
